Pfizer Lyme Disease Vaccine Fails in Trial, Company Will Seek FDA Approval
Thomas Fuller | Nurfoto | fake images Pfizer on Monday said it will seek regulatory approval for a Lyme disease…
iShares US Pharmaceuticals ETF
Eli Lilly's obesity drug retatrutide passes late-stage diabetes trial
The Eli Lilly logo appears at the company's office in San Diego, California, USA, on November 21, 2025. Mike Blake…
FDA approves high-dose version of Novo Nordisk's anti-obesity drug Wegovy
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, on February…
J&J's Icotyde Psoriasis Pill Rivals Tremfya Skyrizi IL-23 Injections
Signs outside the Johnson & Johnson offices in Irvine, California, U.S., on Friday, October 10, 2025. Kyle Grillot Bloomberg |…
Eli Lilly Stock Falls After Analyst's Bearish Call: Here's Our Take
Eli Lilly shares fell 6% on Tuesday and are on track for their worst day since February after a downgrade…
Novo Nordisk ends legal proceedings against Hims & Hers
Nordisk has dropped its legal case against telehealth provider him and her for patent infringement, after the two companies agreed…
Eli Lilly Launches Program to Increase Employer Coverage of Obesity Drugs
Eli Lilly On Thursday it launched a new program designed to help more employers cover obesity medications in the U.S.,…
Why Novo Nordisk's expansion in Ireland is key to fighting Eli Lilly
Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its production capabilities to…
Novartis and Genentech sue for illegal importation of prescription drugs
A sign for Swiss pharmaceutical giant Novartis is seen atop a building in Basel, Switzerland, on September 9, 2025. Fabrice…
What's next for Novo Nordisk's anti-obesity drug CagriSema?
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…